Top Tweets for #highbleedingrisk
Abbreviated #DAPT (1–3 months) after #PCI in #HighBleedingRisk patients reduced bleeding risk without increasing major adverse cardiovascular events compared to standard 6–12-month regimens. https://t.co/FTfKWJZRue
This consensus establishes standardized criteria for identifying #highbleedingrisk (HBR) in #TAVI patients, addressing clinical, anatomical, and procedural factors. It offers a unified approach for evaluating bleeding risk and improving treatment outcomes. #Cardiotwitter @DrGarot @DFCapodanno
https://t.co/GGh7wPKKdK
#cangrelor can be safely administered in patients at #highbleedingrisk undergoing #PCI. Great start for the ICARUS registry during the first day of #SIC83. A heartfelt thank to @ItaloPorto2 @paolocalabro1 @FeliceGragnano, @ChiesiItalia and all those (many!) who have contributed.
Review the latest data for short-term dual anti-platelet therapy in #HighBleedingRisk patients in our HBR #MedEd tutorial series with @AlokeFinn.
See which #Stent types are ideally suited to #DAPT, review patient considerations, and more.
Watch now: 📹: https://t.co/rUL6XitP6d
One-month dual antiplatelet therapy vs ≥3 months dual antiplatelet therapy in #HighBleedingRisk patients did not differ in ischemic risk but lowered bleeding risk: https://t.co/EK29mgpa6M
#JACC #MasterDAPT #cvMI #cvACS #CardioTwitter @FelixMahfoud @GoranEBC @vlgmrc
Interested in HIGH BLEEDING RISK? Read more in our #EIJBestOf article on the PENDULUM Registry by Nakamura M, et al. #dualantiplatelettherapy #highbleedingrisk https://t.co/MBY22p0VQm
Great in person dinner and discussion on #HighBleedingRisk with fantastic colleagues and cath lab staff from @MtnsideMedCtr. Thanks to @AbbottCardio for the opportunity! #ClinicalExcellence #PatientFirst #BeBetter
Access free educational programs via the Coronary Corner, including a webinar series covering #DAPT considerations in #HighBleedingRisk patients. #cardiotwitter #meded https://t.co/GLNzGDRZbg
The #OnyxONE Clear Analysis results, which evaluated complex #HighBleedingRisk patients on 1-month #DAPT, are published. View important risk info: https://t.co/oePOOoyQEa #cardiotwitter #PCI Click to read the article now. https://t.co/V5uuun3PO3
Evaluating complex patients can better inform short #DAPT decisions for #HighBleedingRisk patients.1 View important risk info: https://t.co/Xq7UPASngE #cardiotwitter #PCI Visit our website to learn more about #OnyxONE. https://t.co/Krq86YI1fp
The #OnyxONE Clear Study included highly complex #HighBleedingRisk patients to better inform short #DAPT decisions. View important risk info: https://t.co/5oM9Lu8qch View supporting data on our website. #PCI #cardiotwitter https://t.co/clzCMHNi6t
The #OnyxONE Clear Study included #HighBleedingRisk patients with highly complex lesions. View important risk information: https://t.co/s1mrweEi0q Visit our website to download a #DAPT trial design comparison summary. https://t.co/dqZpJarNoq
Drug-coated Balloons or Drug-eluting Stents – Determining an Optimum Strategy for Patients with High Bleeding Risk
Learn more here: https://t.co/VSyEQZMTuE
#drugelutingstents #highbleedingrisk #antiplatelettherapy #cardiology #cardiologist #cardiovascular
Estimates suggest up to 40% of #PCI patients are #HighBleedingRisk - The SYNERGY MEGATRON Bioabsorbable Polymer (BP) Stent is safe to use in conjunction with shortened DAPT in HBR patients. #cardiotwitter https://t.co/2igxZrjuxy
What do we know about 1-month #DAPT in high ischemic risk, #HighBleedingRisk patients? #cardiotwitter #PCI View important risk info: https://t.co/4OOVBu2zfW
Log in to Medtronic Academy to watch Dr. Kandzari, Dr. Waksman, and Dr. Price discuss.
https://t.co/131u4VdKdz
Log in to Medtronic Academy to watch a physician panel review complex #HighBleedingRisk patient criteria and the latest data evaluating a real-world patient population. View important risk info: https://t.co/WDMhOMWtKS #cardiotwitter #PCI
https://t.co/JUPd8bwqJL
Did you miss the latest webinar reviewing complex #HighBleedingRisk patients from the #OnyxONE Month DAPT Program? #cardiotwitter #PCI View important risk info: https://t.co/hxw9xy3zkk
Log in to Medtronic Academy to watch the latest recording.
https://t.co/YxyJVYkcJr
Access free educational programs via the Coronary Corner, including a webinar series covering #DAPT considerations in #HighBleedingRisk patients. #CardioTwitter #MedEd https://t.co/Bf6uAfWmHl
Don’t miss the live webinar, Complex #HighBleedingRisk Patients in the #OnyxONE Clear Study. Led by Dr. Kandzari, Dr. Waksman, and Dr. Price. View important risk info https://t.co/sGZunoG2mk #cardiotwitter #DAPTchat
Register now! https://t.co/BMnvMJpgLh
Join a live webinar as esteemed panelists discuss Complex #HighBleedingRisk Patients in the #OnyxONE Clear Study. January 28. View important risk info: https://t.co/acKYhpfkHp #PCI #cardiotwitter #DAPTchat
Register now! https://t.co/IOjFqUwVTP
Last Seen Hashtags on Sotwe
latino
Seen from France
pyt
Seen from United States
ديوتْ_بدوي
Seen from United Kingdom
ometv tobrut
Seen from Indonesia
PeaceWithNature
Seen from United States
美濃すき落語会
Seen from United States
nolimit()
Seen from France
momson()+filter:media() - filter:images
sexy18
Seen from Germany
pack famosos
Seen from Chile
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241M followers
Barack Obama
@barackobama
119.2M followers
Cristiano Ronaldo
@cristiano
111.9M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
98M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.2M followers
KATY PERRY
@katyperry
88.4M followers
Taylor Swift
@taylorswift13
82.3M followers
Lady Gaga
@ladygaga
73.8M followers
Virat Kohli
@imvkohli
71.1M followers
Kim Kardashian
@kimkardashian
70.1M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.3M followers
Neymar Jr
@neymarjr
63.9M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.5M followers
X
@x
60.8M followers